a look into the global pioneers & companies
revolutionizing bioprinting.
This company, stationed in San Diego, California, is known for its revolutionary bioprinting technology that has been a large tool in creating a variety of tissues that mimic human biology and disease for pharmaceutical companies to use to test products & for other purposes.
This company, founded in Boca Raton, Florida, specializes in designing electrospun scaffolds from many types of polymer substances. They also provide imaging of fabricated scaffolds, which includes SEM, XPS, ELISA, AFM, and Fluorescence Microscopy, along with using unique manufacturing techniques called lyophilization and cryomilling.
This company located in Tokyo, Japan, is home to a specific bioprinter known as the Regenova, which uses a specific technique called Kenzan: a manufacturing method that allows for the printing of three dimensional cell structures. This company is able to print functional biological components, such as organs, tissues, and so much more.
This company was co-founded by Charles Hull, the inventor of 3D printing, & has grown into a global 3D printing corporation focused on transforming businesses through manufacturing & innovation. Through digitalization, design, & simulation, they are able to optimize their products & processes, thus accelerating the outcomes of 3D printing.
This company based in Buenos Aires, Argentina collaborates with scientists and researchers to launch investigations using bioprinting into areas of health, biology, agriculture, & food. Currently, the company is working on cartilage regeneration and PCL bone substitutes; they aim to improve the fields of regenerative medicine & drug screenings.
This company based in Radebeul, Germany manufactures & markets bone substitution materials mainly based on calcium phosphates for the treatment of bone defects & implant fixation in osteoporotic bone. They are an established supplier to the biomaterials research community with topics and services mainly targeted at bioprinting & regenerative medicine.
This privately-owned company in Sydney, Australia has developed a unique digital bioprinting technology that powers a new innovative platform for 3D cell biology known as RASTRUM. The company focuses on the manufacture & sale of equipment for advanced medical research assays by means of 3D bioprinting.
BIOPRINTING WORLD MAP.
In this new emerging filed, there are over 100 global companies that are leading the way in innovation & advancement.